Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MBRX Moleculin Biotech Inc

4,96

0,01 (0,20%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:31:24

Verzögert um 15 Minuten

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Moleculin Biotech Charts.

Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Moleculin Biotech Charts.

News Moleculin Biotech Inc

Form 8-K - Current report
Donnerstag 16 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress
Donnerstag 16 Mai 2024 (5 Tage vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 15 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)
Mittwoch 15 Mai 2024 (6 Tage vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 14 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Montag 13 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
Montag 13 Mai 2024 (1 Woche vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
Donnerstag 9 Mai 2024 (2 Wochen vor) • PR Newswire (US)

Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast
Mittwoch 8 Mai 2024 (2 Wochen vor) • PR Newswire (US)

Weitere Moleculin Biotech Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen